A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection
- PMID: 35577935
- PMCID: PMC9108708
- DOI: 10.1038/s41431-022-01108-8
A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection
Abstract
COVID-19, the disease caused by SARS-CoV-2, has claimed approximately 5 million lives and 257 million cases reported globally. This virus and disease have significantly affected people worldwide, whether directly and/or indirectly, with a virulent pathogen that continues to evolve as we race to learn how to prevent, control, or cure COVID-19. The focus of this review is on the SARS-CoV-2 virus' mechanism of infection and its proclivity at adapting and restructuring the intracellular environment to support viral replication. We highlight current knowledge and how scientific communities with expertize in viral, cellular, and clinical biology have contributed to increase our understanding of SARS-CoV-2, and how these findings may help explain the widely varied clinical observations of COVID-19 patients.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection.Eur J Hum Genet. 2024 Jan;32(1):10-20. doi: 10.1038/s41431-023-01462-1. Epub 2023 Nov 8. Eur J Hum Genet. 2024. PMID: 37938797 Free PMC article. Review.
-
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.Diagn Microbiol Infect Dis. 2020 Sep;98(1):115094. doi: 10.1016/j.diagmicrobio.2020.115094. Epub 2020 May 30. Diagn Microbiol Infect Dis. 2020. PMID: 32623267 Free PMC article. Review.
-
Molecular Characterization of SARS-CoV-2.Curr Mol Med. 2021;21(7):589-595. doi: 10.2174/1566524020999201203213037. Curr Mol Med. 2021. PMID: 33272175 Review.
-
Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives.World J Gastroenterol. 2021 Jul 21;27(27):4358-4370. doi: 10.3748/wjg.v27.i27.4358. World J Gastroenterol. 2021. PMID: 34366609 Free PMC article. Review.
-
Wuhan to World: The COVID-19 Pandemic.Front Cell Infect Microbiol. 2021 Mar 30;11:596201. doi: 10.3389/fcimb.2021.596201. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33859951 Free PMC article. Review.
Cited by
-
Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools.Int J Mol Sci. 2024 Feb 1;25(3):1798. doi: 10.3390/ijms25031798. Int J Mol Sci. 2024. PMID: 38339078 Free PMC article. Review.
-
SARS-CoV-2 particles promote airway epithelial differentiation and ciliation.Front Bioeng Biotechnol. 2023 Nov 2;11:1268782. doi: 10.3389/fbioe.2023.1268782. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38026867 Free PMC article.
-
Most accurate mutations in SARS-CoV-2 genomes identified in Uzbek patients show novel amino acid changes.Front Med (Lausanne). 2024 May 31;11:1401655. doi: 10.3389/fmed.2024.1401655. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38882660 Free PMC article.
-
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort Study.Vaccines (Basel). 2023 Apr 4;11(4):799. doi: 10.3390/vaccines11040799. Vaccines (Basel). 2023. PMID: 37112711 Free PMC article.
-
Analysis of the abundance and diversity of RNA secondary structure elements in RNA viruses using the RNAsselem Python package.Sci Rep. 2024 Nov 19;14(1):28587. doi: 10.1038/s41598-024-80240-5. Sci Rep. 2024. PMID: 39562668 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous